580 related articles for article (PubMed ID: 25580790)
1. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
Diamantova D; Lomickova I; Cetkovska P
Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
Martina E; Campanati A; Giuliodori K; Offidani A
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
Cline A; Pichardo RO
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
Yazdanyar S; Miller IM; Jemec GB
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
Moyano B; Clemente A; Marín-Jiménez I; Martorell A
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
[TBL] [Abstract][Full Text] [Related]
6. Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab.
Harvin G; Kasarala G
Case Rep Gastroenterol; 2016; 10(1):88-94. PubMed ID: 27403108
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
Martínez F; Nos P; Benlloch S; Ponce J
Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
[TBL] [Abstract][Full Text] [Related]
8. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
[TBL] [Abstract][Full Text] [Related]
9. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
Bassas-Vila J; González Lama Y
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis.
Burmester GR; Gordon KB; Rosenbaum JT; Arikan D; Lau WL; Li P; Faccin F; Panaccione R
Adv Ther; 2020 Jan; 37(1):364-380. PubMed ID: 31748904
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with hidradenitis suppurativa.
Martorell A; Caballero A; González Lama Y; Jiménez-Gallo D; Lázaro Serrano M; Miranda J; Pascual JC; Salgado-Boquete L; Marín-Jiménez I
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():32-42. PubMed ID: 28081768
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease and hidradenitis suppurativa. An uncommon association that responds to infliximab.
Blazquez I; Gonzalez-Lama Y; Roustan G
J Crohns Colitis; 2013 Dec; 7(12):e717-8. PubMed ID: 24080248
[No Abstract] [Full Text] [Related]
14. Steatocystoma multiplex suppurativa associated with hidradenitis suppurativa successfully treated with adalimumab.
Atzori L; Zanniello R; Pilloni L; Rongioletti F
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():42-44. PubMed ID: 31535759
[TBL] [Abstract][Full Text] [Related]
15. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
[TBL] [Abstract][Full Text] [Related]
16. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
Berman HS; Villa NM; Shi VY; Hsiao JL
J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
[TBL] [Abstract][Full Text] [Related]
17. Association and management of Crohn's disease plus hidradenitis suppurativa.
dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
[No Abstract] [Full Text] [Related]
18. Hidradenitis Suppurativa and Crohn's Disease: A Case Series.
Kirthi S; Hellen R; O'Connor R; Connolly M; Tobin AM; McNamara D
Ir Med J; 2017 Aug; 110(7):618. PubMed ID: 29169000
[TBL] [Abstract][Full Text] [Related]
19. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
Yen CF; Huang YH; Chi CC
Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
[TBL] [Abstract][Full Text] [Related]
20. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
Koilakou S; Karapiperis D; Tzathas C
Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
